Diagnosing rheumatic heart disease: where are we now and what are the challenges?

Sarah R de LoizagaAndrea Zawacki BeatonBruno R NascimentoFrederico Vargas Botinha MacedoBreno Camargos Mucelli SpolaorLucas Bretas de PáduaThomas Felipe Silva RibeiroGuilherme Catizani Faria OliveiraLucas Rocha OliveiraLuís Felipe Rezende de AlmeidaThomás Diniz MouraTalisson Taglialegna de BarrosCraig SableMaria Carmo Pereira Nunes

Published in: Expert review of cardiovascular therapy (2021)

Advances in technology and validation of portable echocardiography have made screening and identifying latent RHD feasible in the most burdened regions. However, uncertainty remains around best management of those with latent RHD and best methods to ensure ideal secondary prophylaxis for RHD. Research regarding latent RHD management, as well as continued work on innovative solutions (such as group A streptococcal vaccine), are promising as efforts to improve outcomes of this preventable disease persist.

Keyphrases

pulmonary hypertension
rheumatoid arthritis
left ventricular
computed tomography
emergency department
type diabetes
metabolic syndrome
quality improvement
drug induced